Bruker at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Bruker brings 2 presentations to IDWeek 2026 in Washington, and exhibits at Booth 1732. Its program centres on faster antimicrobial susceptibility testing for blood cultures. One study reports clinical impact and multi-center validation of an AI-powered MALDI-TOF platform for rapid susceptibility results.
| Organization | IDWeek 2026 Attendance |
|---|---|
Bruker Billerica, MA | |
Instrument maker whose MALDI Biotyper identifies microbes from culture in minutes, plus infrared strain typing and ELITechGroup molecular diagnostics. | Booth Exhibiting at Booth 1732 Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm Industry Fri Oct 23 1:30pm–1:50pm Closing the Blood Culture Gap with Rapid Phenotypic Antimicrobial Susceptibility Testing Diagnostics and diagnostic stewardshipAntimicrobials, resistance and stewardship Talk Sat Oct 24 11:15am–11:30am AI-Powered MALDI-TOF Platform for Rapid Antimicrobial Susceptibility Testing: Clinical Impact in Taiwan and Multi-Center Validation in the US Diagnostics and diagnostic stewardshipAntimicrobials, resistance and stewardship |
Instantly find 20 buyers from Bruker
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction